Wexford Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,788
Closed -$554K 199
2024
Q2
$554K Buy
3,788
+695
+22% +$103K 0.14% 99
2024
Q1
$489K Buy
3,093
+968
+46% +$154K 0.1% 130
2023
Q4
$333K Hold
2,125
0.07% 116
2023
Q3
$331K Sell
2,125
-642
-23% -$106K 0.07% 145
2023
Q2
$458K Buy
+2,767
New +$447K 0.09% 117
2020
Q4
Sell
-30,191
Closed -$4.5M 345
2020
Q3
$4.5M Sell
30,191
-26,100
-46% -$3.86M 1.2% 25
2020
Q2
$7.92M Buy
+56,291
New +$8.2M 1.99% 18
2020
Q1
Sell
-97,370
Closed -$14.2M 129
2019
Q4
$14.2M Buy
+97,370
New +$13.2M 2.19% 9

Other funds holding JNJ

Wexford Capital's JNJ Position: Q3 2024 in Review

Wexford Capital sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 3,788 shares — an estimated $554K sold.

Wexford Capital first reported a position in JNJ in Q4 2019 and held it in 8 quarters. The position peaked at $14.2M in Q4 2019. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Wexford Capital reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
  • Wexford Capital sold 3,788 Johnson & Johnson shares in Q3 2024, an estimated $554K.
  • Wexford Capital first reported a position in Johnson & Johnson in Q4 2019 and held it in 8 quarters.
  • Wexford Capital's Johnson & Johnson position peaked at $14.2M in Q4 2019.
  • 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Wexford Capital's 13F filing for Q3 2024, filed 14 Nov 2024.